Sun Pharma, India's largest drugmaker, is set to acquire the remaining 21.52% stake in Israel-based Taro Pharmaceutical Industries for ₹2,891.7 crore. This move will allow Sun Pharma to consolidate control over Taro, as it currently owns 78.48% of the company. Sun Pharma had previously faced resistance from Taro's minority shareholders in its bid to take full control.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.